Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-17

Clinical Trial Update: Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravesical Botulinum toxin A injections for interstitial cystitis refractory to conventional treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Interstitial Cystitis | Phase 2 | Status: COMPLETED